• Sort Blog:
  • All
  • Argomento generico
  • Disinfezione
  • Oncologia
  • Malattie genetiche
  • Malattie renali
  • Problemi metodologici
  • Necrologio
  • Flogosi acute o croniche
  • Malattie da infezione
  • Politica sanitaria
  • Malattie del viaggiatore
  • Patogenesi
  • Malnutrizione
  • Tossinfezion alimentari
  • Squilibri ormonali
  • Uncategorized
  • Malattie da prioni4
  • Rickettsie
  • Fattori di rischio
  • Malattie neurologiche
  • Malattie autoimmuni
  • Batteriologia
  • Malattie da prioni
  • Terapie antinfettive
  • Farmaci antinfiammatori
  • Malattie delle articolazioni
  • Malattie ortopediche
  • Micologia
  • Immunologia
  • Tossicodipendenza
  • Sepsi neonatale
  • inflammatory bowel disease (IBD)
  • Infezioni urinarie
  • Infezioni associate all'assistenza sanitaria
  • Veterinaria
  • Prevenzione
  • Sepsi
  • Febbre
  • Malattie dell'occhio
  • Parassitologia
  • Infezioni atipiche
  • Marcatori d'infezione
  • Varie
  • Terapie palliative
  • Virologia
  • Zoonosi
  • Problemi diagnostici
  • Microbioma
  • Farmacologia
  • Antibiotici
  • Test diagnostici
  • Trapianti d'organo o tessuti
  • Neoplasie
  • Eziologia
  • Micobatteriologia
  • Tossinfezioni alimentari
  • Tecnologia
  • Metagenomica
  • Malattie respiratorie
  • Avvisi ai lettori
  • Fagi
  • Intossicazione alimentare
  • Malattie Tropicali
  • Malattie infiammatorie
  • Ultime notizie
  • antimicotici
  • Genomica
  • Malattie Metaboliche
  • Nutrizione
  • Mal. a trasm. sessuale
  • Medicina ambientale
  • Semeiotica
  • Probiotici
  • Tossicologia
  • Linee guida - Raccomandazioni
  • Epidemie infettive
  • Eruzioni mucocutanee da infezione
  • Marcatore
  • Malattie cardiocircolatorie
  • Vaccinazioni
  • Prognosi delle infezioni
  • Malattie dermatologiche
  • Oculistica
  • Malformazioni congenite

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.LaVange L, Adam SJ, Currier JS, Higgs ES, Reineck LA, Hughes EA, Read SW; ACTIV Therapeutics-Clinical Working Group.Ann Intern Med. 2021 Jun 29:M21-1269. doi: 10.7326/M21-1269. Online ahead of print.PMID: 34181444 Free PMC article.

The U.S. Centers for Disease Control and Prevention (CDC) Supports Microbiome Science, New Publications.

Infectious disease experts at the U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) recently co-edited a special issue of the Journal of Infectious Diseases* featuring 16 review articles on innovative research of the human microbiome. The microbiome is the community of naturally occurring microorganisms in and on our bodies. This work represents ongoing engagement and financial support from CDC’s Antibiotic Resistance (AR) Solutions Initiative to leverage the microbiome for new ways to prevent antibiotic-resistant infections.

* The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance
Ryan T Ranallo, L Clifford McDonald, Alison Laufer Halpin, Thomas Hiltke, Vincent B Young
The Journal of Infectious Diseases, Volume 223, Issue Supplement_3, 15 June 2021, Pages S187–S193, https://doi.org/10.1093/infdis/jiab020

Article: Prospecting Biomarkers for Diagnostic and Therapeutic Approaches in Pythiosis

Article: Prospecting Biomarkers for Diagnostic and Therapeutic Approaches in PythiosisJéssica Luana Chechi, Tiwa Rotchanapreeda, Giselle Souza da Paz, Ana Carolina Prado, Alana Lucena Oliveira, José Cavalcante Souza Vieira, Marília Afonso Rabelo Buzalaf, Anderson Messias Rodrigues, Lucilene Delazari dos Santos, Theerapong Krajaejun and Sandra de Moraes Gimenes BoscoJ. Fungi20217(6), 423; doi:10.3390/jof7060423